LENZ Therapeutics, Inc.
USD5.18
+0.30 (+6.15%)
CEO
Evert Schimmelpennink
IPO Date
2021-06-25
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Country
US
Open
$4.92
Prev. Close
$4.88
Day Low
$4.88
Day High
$5.20
52W Low
$4.68
52W High
$50.40
Market Cap
$0.16B
Volume
1.12M
| 22,100 |
| $6.63 |
| 15 Jun 2026 | Drapkin Kimberlee C | director | A-Award | Acquired | 22,100 | $6.63 |
| 15 Jun 2026 | MCCOLLUM JAMES W | director | A-Award | Acquired | 22,100 | $6.63 |
| 15 Jun 2026 | Thunen Shelley B | director | A-Award | Acquired | 22,100 | $6.63 |
| 15 Jun 2026 | Guerard Frederic | director | A-Award | Acquired | 22,100 | $6.63 |
| 15 Jun 2026 | Scheiner Zachary | director | A-Award | Acquired | 22,100 | $6.63 |
| 30 Mar 2026 | George Jeffrey P. | director | P-Purchase | Acquired | 5,592 | $8.92 |
| 30 Mar 2026 | Schimmelpennink Evert B. | director, officer: President, CEO and Secretary | P-Purchase | Acquired | 28,089 | $8.95 |
| 30 Mar 2026 | Chevallard Daniel R. | Chief Financial Officer | P-Purchase | Acquired | 7,500 | $8.57 |